Vulvovaginal candidiasis in Mato Grosso, Brazil: pregnancy status, causative species and drugs tests
Braz. j. microbiol
; 42(4): 1300-1307, Oct.-Dec. 2011. tab
Artigo
em Inglês
| LILACS
| ID: lil-614588
Biblioteca responsável:
BR32.1
ABSTRACT
Causative agent in majority of VVC is Candida albicans, but infection due to non-C. albicans is common. Use of empiric antifungal therapy in Brazil due to syndromic management of vulvovaginitis could act as risk factor for increase resistance among VVC causative agents. From Mato Grosso patients, 160 with culture-proved among 404 women who had clinical symptoms of VVC, were enrolled in this study. 70 non-pregnant women and 90 pregnant women were included. Candida albicans was the most prevalent, representing 72.9 percent in the non-pregnant group and 92.3 percent in the pregnant group. Differences in species distribution were noted between the two groups, being C. parapsilosis the second more prevalent species among non-pregnant women. Susceptibility testing revealed high susceptibility to fluconazole (except for C. krusei), itraconazole, ketoconazole, and amphotericin B regardless the species (C. albicans, C. parapsilosis, C. tropicalis, C. glabrata, C. krusei) analyzed.
Texto completo:
Disponível
Base de dados:
LILACS
Assunto:
Vulvovaginite
/
Candida albicans
/
Candidíase Vulvovaginal
/
Resistência Microbiana a Medicamentos
/
Técnicas e Procedimentos Diagnósticos
/
Suscetibilidade a Doenças
/
Antifúngicos
Tipo de estudo:
Estudo diagnóstico
/
Estudo de prevalência
/
Fatores de risco
Limite:
Feminino
/
Humanos
País/Região como assunto:
América do Sul
/
Brasil
Idioma:
Inglês
Revista:
Braz. j. microbiol
Ano de publicação:
2011
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS